SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (1397)9/18/2002 10:47:02 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 2243
 
me too, but is there any wonder??...........

>> Rule No. 1, he said, was: "If you can't say something positive, don't say anything at all." Another was: "Go with the flow of other analysts, rather than being contrarian." <<

Message 18004124

It's metastasizing pessimism, metastasizing, necrotizing pessimism. It can't be turned, and those who brought it forward should be in prison. Instead, they're being compensated from a pool of IB revenues, rather than from specific promos?? Nah..... the truth is that many of them took that wealth, moved out of the public eye and public scrutiny, and started hedge funds.

They got to short the crap that they constructed, and it was truly a construction job. They're "out there", living a great life and not showing a tad of shame.

It's newbies, and the few veterans who never prostituted themselves in the first place, who are working from that new pool.

Some SI biofreaks were pointing to the biodeals, the HGSI and (worse!) Celera deals. etc., etc. The pointers are here at SI, real-time.



To: mopgcw who wrote (1397)9/19/2002 1:10:17 AM
From: Spekulatius  Respond to of 2243
 
Even though RIGL delivered on its business plan, RIGL is in a bind since its business plan will not work in the current climate. RIGL is very early stage but the market does not assign any value to technology and early stage pipeline. In my opinion, RIGL is a good biotech company started at the wrong time. A cash rich biotech with vision (MLNM, CRGN, CRA) should by them,IMO.